Fresenius Medical Care (NYSE:FMS) Hits New 52-Week High – Here’s What Happened

Fresenius Medical Care AG (NYSE:FMS) reached a new 52-week high on Tuesday . The company traded as high as $23.35 and last traded at $23.35, with a volume of 9134 shares changing hands. The stock had previously closed at $22.78.

Analyst Upgrades and Downgrades

FMS has been the subject of a number of recent analyst reports. Berenberg Bank initiated coverage on Fresenius Medical Care in a research report on Wednesday, November 6th. They set a “buy” rating and a $25.60 price target for the company. Truist Financial upped their price target on Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. StockNews.com began coverage on Fresenius Medical Care in a research note on Thursday, November 28th. They issued a “strong-buy” rating on the stock. Finally, Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday. One analyst has rated the stock with a sell rating, two have issued a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Fresenius Medical Care presently has a consensus rating of “Hold” and a consensus target price of $24.30.

Fresenius Medical Care Price Performance

The firm has a market capitalization of $13.69 billion, a P/E ratio of 18.83, a PEG ratio of 1.00 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The firm has a 50-day moving average of $20.97 and a 200-day moving average of $20.30.

Hedge Funds Weigh In On Fresenius Medical Care

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Franklin Resources Inc. lifted its position in Fresenius Medical Care by 3.3% in the 3rd quarter. Franklin Resources Inc. now owns 74,640 shares of the company’s stock valued at $1,490,000 after acquiring an additional 2,386 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in Fresenius Medical Care in the 3rd quarter valued at approximately $38,000. MML Investors Services LLC lifted its position in Fresenius Medical Care by 5.3% in the 3rd quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after acquiring an additional 753 shares in the last quarter. XTX Topco Ltd lifted its holdings in shares of Fresenius Medical Care by 70.8% during the 3rd quarter. XTX Topco Ltd now owns 39,769 shares of the company’s stock valued at $847,000 after buying an additional 16,487 shares during the period. Finally, National Bank of Canada FI lifted its holdings in shares of Fresenius Medical Care by 17.4% during the 3rd quarter. National Bank of Canada FI now owns 23,270 shares of the company’s stock valued at $496,000 after buying an additional 3,451 shares during the period. 8.25% of the stock is owned by institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.